MarketWatch: Cancer
Pages: 29
Publisher: Datamonitor
Date Published: March 2006
Format: PDF
Price: $200
Overview
Datamonitor’s Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventures, and regulatory decisions.
Table of Contents
In this month’s MarketWatch…
This month’s highlights
Page 2 – Key Announcements
Page 2 – Cancer News Round-up
Brain and Neuroendocrine Cancers News
Page 4 – News Headlines
Page 4 – Brain Cancer Update
Page 5 – Neuroendocrine Cancers Update
Lung Cancer News
Page 7 – Opinion
Page 8 – News Headlines
Page 8 – Research & Development Update
Page 9 – Regulatory Update
Digestive System Cancers News
Page 11 – Opinion
Page 14 – News Headlines
Page 14 – Colorectal Cancer Update Update
Page 15 – Stomach Cancer Update
Page 16 – Gastrointestinal Cancer Update
Feature Analysis
Page 17 – Can therapeutic vaccines fulfill their promise?
Company Spotlight
Page 20 – Biogen Idec
Index
Page 28 – Pharma companies
Page 28 – Biotech companies
Page 29 – Key drugs
